Invesaro

Stocks Health care INCR

NASDAQ · Health care

Intercure Ltd. (INCR)

Intercure Ltd. reported revenue of ₪238.8M in fiscal 2024, down 32.8% from a year earlier. It posted a net loss of ₪67.8M. In fiscal 2024 capital spending exceeded operating cash flow by ₪71.3M. At December 31, 2024 it held ₪78.3M in cash against ₪183M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on April 30, 2026.

Revenue (FY2024)
₪238.8M
-32.8% year on year
Net margin
-28.4%

What Intercure Ltd. does

Intercure Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker INCR.

Revenue and profit by year

Revenue
FY19: ₪8.9M ₪8.9M FY19FY21: ₪65M ₪65M FY21FY21: ₪219.7M ₪219.7M FY21FY22: ₪388.7M ₪388.7M FY22FY23: ₪355.6M ₪355.6M FY23FY24: ₪238.8M ₪238.8M FY24
Net income
FY19: -₪5.9M -₪5.9M FY19FY21: -₪37.2M -₪37.2M FY21FY21: ₪4.7M ₪4.7M FY21FY22: ₪44.8M ₪44.8M FY22FY23: -₪62M -₪62M FY23FY24: -₪67.8M -₪67.8M FY24

Fiscal years as reported in annual reports. Amounts in ILS.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2024₪238.8M-₪67.2M-₪67.8M-₪1.48-₪71.3M
2023₪355.6M-₪41.6M-₪62M-₪1.36-₪56.3M
2022₪388.7M₪50.6M₪44.8M₪0.99₪31.5M
2021₪219.7M₪28.2M₪4.7M₪0.11₪16.1M
2021₪65M-₪38.4M-₪37.2M-₪1.42-₪12.9M
2019₪8.9M-₪3.4M-₪5.9M-₪0.25-₪39.7M

Latest SEC filings

What Intercure Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. September 8, 2026
  2. August 27, 2026
  3. August 26, 2026
  4. August 24, 2026
  5. August 11, 2026
  6. August 4, 2026
  7. July 27, 2026
  8. July 22, 2026
  9. June 22, 2026
  10. June 15, 2026

Recent insider filings (Forms 3, 4 and 144): 7, the latest on August 24, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about INCR

What does Intercure Ltd. do?

Intercure Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker INCR.

Is Intercure Ltd. profitable?

No. In fiscal 2024 it reported a net loss of ₪67.8M on revenue of ₪238.8M.

How much revenue does Intercure Ltd. make?

In fiscal 2024 Intercure Ltd. reported revenue of ₪238.8M. That is 32.8% less than a year earlier.

When did Intercure Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on April 30, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 8, 2026.

Similar companies

Follow INCR

Get an email when Intercure Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow INCR: get an email when it files

Where the numbers come from

Financial figures are the values Intercure Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.